MeCP2在Rett综合征中的调控机制

doi:10.3724/SP.J.1005.2014.0625

遗传 ›› 2014, Vol. 36 ›› Issue (7): 625-630.doi: 10.3724/SP.J.1005.2014.0625

• 综述 • 下一篇

MeCP2在Rett综合征中的调控机制

杨文旭, 潘虹

北京大学第一医院实验中心, 北京 100034

收稿日期:2013-12-05 出版日期:2014-07-20 发布日期:2014-06-23
通讯作者: 潘虹, 硕士, 研究员, 研究方向：小儿神经遗传。E-mail: panmuren@263.net
作者简介:杨文旭, 在读博士研究生, 研究方向：小儿神经遗传。E-mail: mei_mei_yang@163.com
基金资助:
国家自然科学基金项目(编号: 81070911)资助

Regulation mechanism and research progress of MeCP2 in Rett syndrome

WenxuYang, Hong Pan

Department of Central Laboratory, First Hospital, Peking University, Beijing 100034, China

Received:2013-12-05 Online:2014-07-20 Published:2014-06-23

摘要/Abstract

摘要： Rett综合征(Rett syndrome, RTT)是一种X连锁的神经发育障碍性遗传病, 是导致女性严重智力障碍的主要原因之一。编码甲基化CpG结合蛋白2(Methyl-CpG-binding protein 2, MeCP2)基因突变是RTT主要的遗传病理学改变, MeCP2作为转录抑制因子调控基因表达。在RTT发病机制中, 由于缺乏MeCP2与甲基化DNA的正确结合, 阻碍了它对下游靶基因表达的正常调控, 最终导致脑功能障碍。目前, 对MeCP2在脑发育过程中的作用以及如何导致RTT的发生, 其机制尚不清楚。文章从MECP2基因和MeCP2蛋白两个方面, 对基因结构、蛋白质功能以及在分子水平上的调控机制进行了综述, 以期为RTT的发病机制研究提供新思路。

关键词: Rett综合征, 甲基化CpG结合蛋白2, 基因, DNA甲基化

Abstract: Rett syndrome (RTT) is an X-linked neurodevelopmental disease accountable for some of the severe mental retardation of females. Mutations in the gene encoding mythyl-CpG-binding protein 2, MeCP2, which acts as a suppressor of gene expression, are the primary genetic pathological change of RTT. Insufficient binding of MeCP2 with methylated DNA disrupts the proper expression of target genes and results in brain dysfunction. Currently, the proper role MeCP2 played in the process of brain development and the occurrence of RTT remain elusive. In this review, we summarize both the MECP2 gene and MeCP2 protein, with highlight upon their structures, functions and more importantly their regulatory mechanisms at the molecular level so as to elucidate the mechanisms underlying the pathogenesis of RTT.

Key words: Rett syndrome, methyl-CpG-binding protein 2, gene, DNA methylation

杨文旭, 潘虹. MeCP2在Rett综合征中的调控机制[J]. 遗传, 2014, 36(7): 625-630.

WenxuYang, Hong Pan. Regulation mechanism and research progress of MeCP2 in Rett syndrome[J]. HEREDITAS(Beijing), 2014, 36(7): 625-630.

参考文献

[1] JD, Meehan RR, Henzel WJ, Maurer-Fogy I, Jeppesen P, Klein F, Bird A. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell , 1992, 69(6): 905-914.
[2] X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN, Bird A. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature , 1998, 393(6683): 386-389.
[3] DH, Peddada S, Bieda MC, Vallero RO, Hogart A, Nagarajan RP, Thatcher KN, Farnham PJ, Lasalle JM. Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Proc Natl Acad Sci US A , 2007, 104(49): 19416-19421.
[4] X, Bao X, Zhang J, Zhao Y, Cao G, Pan H, Wei L, Wu X. Molecular characteristics of Chinese patients with Rett syndrome. Eur J Med Genet , 2012, 55(12): 677-681.
[5] RS, Lane JB, Childers J, Skinner SA, Annese F, Barrish JO, Glaze DG, Macleod P, Percy AK. Longevity in Rett syndrome: analysis of the North American Database. J Pediatr , 2010, 156(1): 135-138.
[6] JL, Kaufmann WE, Glaze DG, Christodoulou J, Clarke AJ, Bahi-Buisson N, Leonard H, Bailey ME, Schanen NC, Zappella M, Renieri A, Huppke P, Percy AK. Rett syndrome: revised diagnostic criteria and nomenclature. Ann Neurol , 2010, 68(6): 944-950.
[7] R, Parrini E. Epilepsy in Rett syndrome, and CDKL5-and FOXG1-gene-related encephalopathies. Epilepsia , 2012, 53(12): 2067-2078.
[8] MR, Pan H, Bao XH, Zhang YZ, Wu XR. MECP2 and CDKL5 gene mutation analysis in Chinese patients with Rett syndrome. J Hum Genet , 2007, 52(1): 38-47.
[9] T, Chelly J. Molecular genetics of Rett syndrome: when DNA methylation goes unrecognized. Nat Rev Genet , 2006, 7(6): 415-426.
[10] M, Zoghbi HY. The story of Rett syndrome: from clinic to neurobiology. Neuron , 2007, 56(3): 422-437.
[11] E, Longo I, Ottimo F, Speciale C, Sampieri K, Katzaki E, Artuso R, Mencarelli MA, D'Ambrogio T, Vonella G, Zappella M, Hayek G, Battaglia A, Mari F, Renieri A, Ariani F. MECP2 deletions and genotype-phenotype correlation in Rett syndrome. Am J Med Genet A , 2007, 143A(23): 2775-2784.
[12] L, De Filippis B, Laviola G. Mouse models of Rett syndrome: from behavioural phenotyping to preclinical evaluation of new therapeutic approaches. Behav Pharmacol , 2008, 19(5-6): 501-517.
[13] P, Ogier M, Brooks-Harris G, Schmid DA, Katz DM, Nelson SB. Pathophysiology of locus ceruleus neurons in a mouse model of Rett syndrome. J Neurosci , 2009, 29(39): 12187-12195.
[14] L, Shepherd GM. Synaptic circuit abnormalities of motor-frontal layer 2/3 pyramidal neurons in a mutant mouse model of Rett syndrome. Neurobiol Dis , 2010, 38(2): 281-287.
[15] G, Hablitz JJ, Pozzo-Miller L. Network hyperexcitability in hippocampal slices from Mecp2 mutant mice revealed by voltage-sensitive dye imaging. J Neurophysiol , 2011, 105(4): 1768-1784.
[16] B, Soto CJ, Saez M, Abrams A, Walz K, Young JI. Transgenic complementation of MeCP2 deficiency: phenotypic rescue of Mecp2-null mice by isoform-specific transgenes. Eur J Hum Genet , 2012, 20(1): 69-76.
[17] JM, Kim YH, Arnold AP, Schanen NC. Differential distribution of the MeCP2 splice variants in the postnatal mouse brain. J Comp Neurol , 2007, 501(4): 526-542.
[18] PJ, Illingworth RS, Webb S, Kerr AR, James KD, Turner DJ, Andrews R, Bird AP. Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. Mol Cell , 2010, 37(4): 457-468.
[19] N, Lioy DT, Grunseich C, Mandel G. Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology. Nat Neurosci , 2009, 12(3): 311-317.
[20] I, Jin LW. Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate. J Neurosci , 2010, 30(15): 5346-5356.
[21] RP, Nikitina T, Horowitz-Scherer RA, Gierasch LM, Uversky VN, Hite K, Hansen JC, Woodcock CL. Unique physical properties and interactions of the domains of methylated DNA binding protein 2. Biochemistry , 2010, 49(20): 4395-4410.
[22] RP, Horowitz-Scherer RA, Nikitina T, Gierasch LM, Woodcock CL. Rett syndrome-causing mutations in human MeCP2 result in diverse structural changes that impact folding and DNA interactions. J Biol Chem , 2008, 283(29): 20523-20534.
[23] G, Conca B, Bergo A, Rusconi L, Zhou Z, Greenberg ME, Landsberger N, Soddu S, Kilstrup-Nielsen C. Methyl-CpG-binding protein 2 is phosphorylated by homeodomain-interacting protein kinase 2 and contributes to apoptosis. EMBO Rep , 2009, 10(12): 1327-1333.
[24] J, Hu K, Chang Q, Wu H, Sherman NE, Martinowich K, Klose RJ, Schanen C, Jaenisch R, Wang W, Sun YE. Phosphorylation of MeCP2 at Serine 80 regulates its chromatin association and neurological function. Proc Natl Acad Sci USA , 2009, 106(12): 4882-4887.
[25] YL, Pawson T, Dikic I. Post-translational modifications in signal integration. Nat Struct Mol Biol , 2010, 17(6): 666-672.
[26] ME, Lioy DT, Ma L, Impey S, Mandel G, Goodman RH. Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA. Nat Neurosci , 2007, 10(12): 1513-1514.
[27] L, Makedonski K, Kaufman Y, Razin A, Shemer R. MeCP2 deficiency in the brain decreases BDNF levels by REST/CoREST-mediated repression and increases TRKB production. Epigenetics , 2007, 2(4): 214-222.
[28] RP, Horowitz-Scherer RA, Nikitina T, Shlyakhtenko LS, Woodcock CL. MeCP2 binds cooperatively to its substrate and competes with histone H1 for chromatin binding sites. Mol Cell Biol , 2010, 30(19): 4656-4670.
[29] KL, McNae IW, Schmiedeberg L, Klose RJ, Bird AP, Walkinshaw MD. MeCP2 binding to DNA depends upon hydration at methyl-CpG. Mol Cell , 2008, 29(4): 525-531.
[30] T, Shi X, Ghosh RP, Horowitz-Scherer RA, Hansen JC, Woodcock CL. Multiple modes of interaction between the methylated DNA binding protein MeCP2 and chromatin. Mol Cell Biol , 2007, 27(3): 864-877.
[31] VH, McBryant SJ, Wade PA, Woodcock CL, Hansen JC. Intrinsic disorder and autonomous domain function in the multifunctional nuclear protein, MeCP2. J Biol Chem , 2007, 282(20): 15057-15064.
[32] PT, Horowitz-Scherer RA, Adkins N, Woodcock CL, Wade PA, Hansen JC. Chromatin compaction by human MeCP2. Assembly of novel secondary chromatin structures in the absence of DNA methylation. J Biol Chem , 2003, 278(34): 32181-32188.
[33] D, Fu XD. DNA interaction networks: an information highway for regulated gene expression in the 3-dimentional space of the nucleus. Cell Res , 2009, 19(12): 1316-1319.
[34] RE, Rhodes SJ. The role of DNA methylation in regulation of the murine Lhx3 gene. Gene , 2014, 534(2): 272-281.
[35] S, McMillan HJ, Doja A, Humphreys P. Adolescent onset cognitive regression and neuropsychiatric symptoms associated with the A140V MECP2 mutation. Dev Med Child Neurol , 2014, 56(1): 91-94.
[36] DS, Chuang TP, Chiang MF, Ho CS, Hsiao CD, Huang YW, Wu TY, Wu JY, Chen YT, Chen TC, Li LH. De novo MECP2 duplication derived from paternal germ line result in dysmorphism and developmental delay. Gene , 2014, 533(1): 78-85.
[37] M, Wither RG, Colic S, Wu C, Monnier PP, Bardakjian BL, Zhang L, Eubanks JH. Rescue of behavioral and EEG deficits in male and female Mecp2-deficient mice by delayed Mecp2 gene reactivation. Hum Mol Genet , 2014, 23(2): 303-318.
[38] CM, Kaufmann WE, Bressler JP. MeCP2 deficiency enhances glutamate release through NF-kappaB signaling in myeloid derived cells. J Neuroimmunol , 2013, 265(1-2): 61-67.
[39] Merrer J, Becker JA, Befort K, Kieffer BL. Reward processing by the opioid system in the brain. Physiol Rev , 2009, 89(4): 1379-1412.
[40] E, Braissant O. Synthesis and transport of creatine in the CNS: importance for cerebral functions. J Neurochem , 2010, 115(2): 297-313.

编辑推荐

Metrics

www.chinagene.cn
备案号：京ICP备09063187号-4
总访问:,今日访问:,当前在线:

MeCP2在Rett综合征中的调控机制

Regulation mechanism and research progress of MeCP2 in Rett syndrome

PDF (PC)

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	杨新萍,于媛,许操. 重新设计与快速驯化创造新型作物[J]. 遗传, 2019, 41(9): 827-835.
[2]	梁承志. 从作物基因组分析到整合组学知识库建设[J]. 遗传, 2019, 41(9): 875-882.
[3]	姜义圣,许执恒. 脑发育疾病及发病机制[J]. 遗传, 2019, 41(9): 801-815.
[4]	刘永鑫,秦媛,郭晓璇,白洋. 微生物组数据分析方法与应用[J]. 遗传, 2019, 41(9): 845-862.
[5]	史晓黎,何伊琳,凌宏清. 小麦A基因组测序与进化研究进展[J]. 遗传, 2019, 41(9): 836-844.
[6]	张秀泉,王建,熊符,吕伟标,周远青,杨少民,张玉婷,田小燕,连蔚,徐湘民. 染色体10q24.31片段重复导致先天性缺指/缺趾畸形的一个家系致病机理分析[J]. 遗传, 2019, 41(8): 716-724.
[7]	张桂权. 基于SSSL文库的水稻设计育种平台[J]. 遗传, 2019, 41(8): 754-760.
[8]	莫健新,王豪强,黄广燕,蔡更元,吴珍芳,张献伟. 微生物源果胶酶在猪PK15细胞中异源表达及其酶学性质分析[J]. 遗传, 2019, 41(8): 736-745.
[9]	王博,刘芳,张二春,沃晨亮,陈振家,钱璞毅,卢浩荣,曾文君,陈泰,危金普,万仟,王韧,徐讯. 国家基因库：共有、共为、共享[J]. 遗传, 2019, 41(8): 761-772.
[10]	张倩倩,商璇,林宛颖,徐湘民. 影响β-地中海贫血表型的遗传修饰作用[J]. 遗传, 2019, 41(8): 669-676.
[11]	梁文权,侯豫,赵存友. 精神分裂症相关单核苷酸多态性调控microRNA功能研究进展[J]. 遗传, 2019, 41(8): 677-685.
[12]	禹奇超,宋彬,邹轩轩,王岭,刘德权,李波,马昆. 乳腺癌癌旁组织特异性表达基因分析[J]. 遗传, 2019, 41(7): 625-633.
[13]	李智,何俊,蒋隽,Richard G. Tait Jr.,Stewart Bauck,过伟,吴晓林. 牛SNP芯片分型检出率和分型错误率对基因型填充准确率的影响[J]. 遗传, 2019, 41(7): 644-652.
[14]	牛煦然,尹树明,陈曦,邵婷婷,李大力. 基因编辑技术及其在疾病治疗中的研究进展[J]. 遗传, 2019, 41(7): 582-598.
[15]	何俊,Fernando B. Lopes,吴晓林. 动物基因组选配方法与应用[J]. 遗传, 2019, 41(6): 486-493.